Nicorette Supermint (Nicotine)

Nicotine in the lozenge acts as a partial agonist at nicotinic acetylcholine receptors, providing enough stimulation to lessen withdrawal while blocking the rewarding effects of smoked nicotine, thereby supporting a gradual reduction in cigarette use.

The specific dosing regimen is determined by the prescribing healthcare professional based on the individual’s smoking history, dependence level, and treatment goals. Patients should follow the prescriber’s instructions and the product label.

The safety of nicotine replacement therapy during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicorette Supermint is a lozenge that delivers nicotine through the oral mucosa, offering a discreet, chew‑free alternative to nicotine gum or patches. It provides rapid onset of relief and can be used on an as‑needed basis, whereas patches deliver a steady dose over 24 hours.

Store the lozenges at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and direct sunlight. Keep out of reach of children and do not use after the expiration date.

Place one lozenge in the mouth and allow it to dissolve slowly, moving it around the oral cavity as needed. Do not chew or swallow whole; the lozenge should dissolve completely before swallowing any remaining saliva.

Serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular events like chest pain or irregular heartbeat. If any of these occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to nicotine or any excipients in the lozenge, children under 18 years, and patients with certain cardiovascular conditions should avoid using Nicorette Supermint unless advised otherwise by a qualified healthcare professional.